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The induction of a delayed-type cell-mediated immune response in the skin of
leprosy patients leads to extensive mononuclear cell accumulation in the dermis and
alterations in the keratinocytes ofthe overlying epidermis (1) . This includes keratinocyte
proliferation, epidermal thickening, the expression of IFN-y-induced peptide, IP-
10 (2), and surface Ia antigen (1) . Intradermal injection ofhuman rIFN-y into the
skin of leprosy patients mimics the delayed cellular response to soluble antigen (3,
4) . Not only are mononuclear leukocytes recruited into the dermal site, but prolifer-
ation and antigenic changes of the epidermal keratinocytes are also observed. In
an effort to better understand the intercellular dialogues that occur in a cutaneous
cell-mediated immune response, we have developed an in vitro assay to detect changes
in keratinocyte multiplication in response to inflammatory cell supernatants and
purified or recombinant cytokines . Evidence is presented that activated PBMC pro-
duce factors that modify keratinocyte growth and differentiation . Our results sug-
gest that T lymphocytes are the cells responsible for this activity . We show that IFN-
y and transforming growth factor ß (TGFß)t inhibit keratinocyte growth, whereas
IL-3 and granulocyte/monocyte colony-stimulating factor(GM-CSF) stimulate ker-
atinocyte growth .
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Materials and Methods
Human Keratinocyte Cultures.
￿
All experiments used normal human epidermal keratinocytes
(NHEK ; Clonectics Corp., San Diego, CA) at third passage . Cells were grown in modified
MCDB 153 medium and keratinocyte growth medium(KGM) (Clonetics Corp .) . KGM con-
sists of MCDB 153 medium plus the added growth factors : epidermal growth factor (EGF,
10 ng/ml), insulin (5 gg/ml), hydrocortisone (0.5 gg/ml), and bovine pituitary extract pro-
tein (BPE, 70 gg/ml). Our basal medium was MCDB 153 medium and contained growth-
limiting concentrations of hydrocortisone (10 ng/ml), insulin (100 ng/ml), and BPE (1.3 to
2.6 gg protein/ml) . Second-passaged NHEK were grown in KGM on plastic 25-cm 2 tissue
culture flasks (Corning Glass Works, Corning, NY) . Under these conditions, >96% of the
keratinocytes were proliferating basal cells (5) and were free of fibroblast contamination (6) .
At80-90% confluence, the keratinocytes were trypsinized (0.25% trypsin/0.02To EDTA ; Gibco
Laboratories, Grand Island, NY) to single cell suspensions, washed inMCDB 153, and seeded
in 24-well plates (Costar, Cambridge, MA) for growth assays .
This research was supported by U. S. Public Health Service grant A1-22616 .
1 Abbreviations used in this paper. BPE, bovine pituitary extract protein ; DC, dendritic cell ; EGF,
epidermal growth factor ; FGF, fibroblast growth factor ; GM-CSF, granulocyte/macrophage colony-
stimulating factor; KGM, keratinocyte growth medium; M-CSF, macrophage CSF ; NHEK, normal
human epidermal keratinocytes ; PDGF, platelet-derived growth factor; TGR0, transforming growth
factor ß .
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In Vitro Keratinocyte Growth Assay.
￿
Keratinocytes were seeded at 5 x 103 to 104 keratino-
cytes per well in KGM. After overnight culture (37°C, 5% COZ) the nonadherent keratino-
cytes were aspirated and 1 ml MCDB 153 medium was added. Plating efficiencywas usually
30%. At 48-72 h of culture, the MCDB 153 medium was replaced with 1 ml of fresh basal
medium with or without increasing concentrations of purified or recombinant cytokine, growth
factor, or inflammatory cell supernatant, and cultured for 48-96 h. Cell counts were per-
formed on triplicate trypsinized cultures using a Coulter Counter (Model ZF; Coulter Elec-
tronics, Hialeah, FL). Cell viability was evaluated by Trypan Blue exclusion (0.4%, Sigma
Chemical Co., St. Louis, MO) and was >95%.
Cytokines and Growth Factors.
￿
EGF, insulin, hydrocortisone, and BPE were obtained from
Clonetics Corp.; purified human TGF-0, human rIL-1(3, human rIL-2, and purified human
platelet-derived growth factor (PDGF) from Collaborative Research (Bedford, MA); human
rIL-3, macrophage colony-stimulating factor (M-CSF), and GM-CSF from Genetics Insti-
tute (Cambridge, MA); purified human fibroblast growth factor (FGF [basic]) from Rafael
Mira y Lopez (The Rockefeller University), and human rIFN-y from Genentech (San Fran-
cisco, CA).
Con A-stimulated PBMC Supernatants.
￿
Human PBMC (platelet-free, reference 7) obtained
from buffy coats (New York Blood Center, New York, NY) were separated on Ficoll-pacque
(Pharmacia Fine Chemicals, Piscataway, NJ), washed, and cultured (2 x 106/ml) for 0-96 h
in serum-free MCDB 153 medium containing 1 jig Con A/ml (Pharmacia). Harvested super-
natants were clarified by centrifugation (500 g), stored at -20°C, and freshly thawed before use.
Supernatantsfrom MixedLeukocyteReactions (MLR).
￿
Allo-MLR supernatants were obtained
by using monocyte or dendritic cell (DC) and T lymphocyte enriched populations (8). Briefly,
3 x 105 irradiated (3,000 rad, '37Cs) monocytes or DC were incubated 7 d with 107 allogeneic
respondingT cells in 10 ml RPMI 1640 (Gibco Laboratories) supplemented with 100 U peni-
cillin/ml, 100 wg streptomycin/ml, 2 mM glutamine, and 10% AB' human serum. Super-
natants were clarified by centrifugation (500 g) and stored at -20°C until use.
Results
Growth Assay.
￿
Measurement of human keratinocyte growth in vitro generally is
determined by an increase in colony number or area after 2 wk ofculture in 60-mm
dishes (9-11). Such assays use primary isolated keratinocytes potentially contami-
nated with dermal fibroblasts or use serum in addition to irradiated fibroblast feeder
layers. Thus analysis of the direct effect of an added putative growth factor on ker-
atinocyte replication is difficult. Others have used thymidine uptake as an indicator
ofproliferation (12), but this has had no correlation with in vitro keratinocyte growth
(13) as human keratinocytes have been shownto catabolize thymidine (14). To deter-
mine the effects that factor(s) generated locally during a cutaneous cell-mediated
response have on keratinocyte replication, we have developed an assay that uses pri-
mary human keratinocytes free of fibroblasts, feeder layers, and cultured in serum-
free medium. This system allows us to measure keratinocyte multiplication by changes
in cell number. In contrast to other bioassays, this yields results within 72-96 h.
Keratinocyte Growth in KGM vs. MCDB 153.
￿
Fig. 1 shows the kinetics of keratino-
cyte replication in complete (KGM) medium (with added growth factors) compared
with that observed in basal MCDB 153 medium alone. 48 h after culture, keratino-
cyte growth was greater in KGM than in MCDB 153 medium. By 96 h, this differ-
ence was accentuated as cells cultured in MCDB 153 medium ceased to divide. Al-
though keratinocytes failed to divide in MCDB 153 medium, they were still viable
and could be stimulated to multiply if growth factors were added to the medium
(datanot shown). Thus the range available to measure stimulatory/inhibitory factor(s)
on keratinocyte growth is from N6-18 x 104'/well at 96 h of culture.12
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FIGURE 1.
￿
In vitrokeratinocyte replication. Humankeratinocytes
were cultured for96 heither in KGM (')or MCDB 153 medium
(x)alone. (Inset) Keratinocytes were cultured with increasing con-
centrations of BPE protein/ml MCDB 153 medium (100 ng in-
sulin/ml and10 nghydrocortisone/ml) for48(O)and72 (")hours.
Results are expressed as the mean of triplicate wells t 1 SEM.
To detect inhibitory and/or stimulatory molecules generatedduring a local inflam-
matory response, it was necessary to modify the medium such that it would main-
tain alowlevel ofkeratinocyte proliferation. In ourassay hydrocortisone andinsulin
(10ng/ml and 100 ng/ml MCDB 153, respectively)allowkeratinocyte multiplication
(not shown). EGF was not mitogenic in our assay as reported by others (15, 16).
Fig. 1 (inset) demonstrates the effect of increasing concentrations of BPE protein
on keratinocytes in the presence ofhydrocortisone andinsulin. At 48 h, the number
of keratinocytes recovered from wells containing 70 ttgBPE protein/ml medium was
almost double that ofwellswithoutBPEprotein. After 72 h ofculture this difference
was nearly threefold. Consequently, growth experiments used a basal medium that
contained MCDB 153 medium with hydrocortisone (10 ng/ml), insulin (100 ng/ml),
and BPE protein (1.3-2.6 ug/ml) and resulted in an approximate doubling in cell
number every 48 h.
Keratinocyte Growth Factors GeneratedbyActivatedImmune Cells.
￿
Fig. 2 showsthe regula-
tory factorsproduced in vitro by human PBMC stimulated for 24-72 h with or without
1 ug Con A/ml MCDB 153 medium. Culture of keratinocytes for 72 h in 33% Con
A-stimulated PBMC supernatants inhibited cell growth (Fig. 2A) as compared with
supernatants from unstimulated PBMC that possess stimulatory properties at this
concentration (Fig. 2 B). In fact, the activity found in the control PBMC superna-
tants was as stimulatory as complete medium. Stimulatory activity (45%) was also
observed with a low concentration (0.01%) of Con A-stimulated PBMC superna-
tant. Con A itself did not have suppressive or stimulatory effects (Fig. 2 C). Thus,
both Con A-stimulated and nonstimulated cell supernatants contain stimulatory1398
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FIGURE 2.
￿
Theeffect ofhuman PBMC supernatants on in vitro
keratinocyte growth. Supernatants were obtained from human
PBMC cultured with (A)or without(B, C) 1 ug Con A/ml MCDB
153 medium from 24 to 72 h. Percent stimulation of keratinocyte
growth above that obtained with basal medium alone (abscissa)
was determined after 72 h of culture. The average oftwo such ex-
periments is shown. (C) Addition of 1 tag Con A/ml to superna-
tants from PBMC not activated with Con A. [3H]TdR incorpo-
ration for PBMC stimulated with Con A (1.8 x 103 cpm) were
10-fold greater than nonstimulated cultures (0.1 x 10 cpm).
factors for keratinocyte replication, but at different effective concentrations (0.01%
and 1017o, respectively).
The Effect of Human Allo-MLR Supernatants on Keratinocyte Growth.
￿
To identify the
mononuclear cell responsible for the keratinocyte growth factors found in PBMC
supernatants, allo-MLR supernatants were generated. Fig. 3 shows data in which
supernatants from bulk PBMC, plastic adherent monocytes, and T lymphocytes
stimulated with either irradiated monocytes or DC were examined for their stimula-
tory properties after 48 h of culture. To examinethis property in the absenceof serum
inhibitory factors, all supernatants were diluted to 1% of culture medium. At this
concentrationvery little effect was observed in supernatants from nonstimulated mono-
cytes, PBMC, or basal medium. In contrast ; both 7-d MLR supernatants contained
molecule(s) capable of stimulating keratinocyte replication. The percent stimula-
tion of DC-activated T lymphocytes was almost twice that of monocyte-activated
T cells. This suggests that T lymphocytes, rather than monocytes are the cells
producing and releasing keratinocyte growth-promoting molecules.
Keratinocyte Replication After Culture with Recombinant or Highly Purled Cytokines and
Growth Factors. Cytokines that might be produced in the in situ environment and
modify keratinocyte growth were examined. This revealed that GM-CSF and IL-3
possessed stimulatory properties (Fig. 4, A and B), while TGFR and IFN-'Y were
potent inhibitors of keratinocyte replication (Fig. 4, CandD). Peak stimulationwith
GM-CSF occurred at 0.6 ng/ml basalmedium (Fig. 4A), whereas the peak stimula-
tory activity for IL-3 occurred at 2.5 ng/mI basal medium (Fig. 4 B). The stimula-
tory effect of IL-3 was enhanced by adding fresh lymphokine at 24-h intervals.
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FIGURE 3.
￿
Keratinocyte growth afterculture in allo-MLR
supernatants. The figure represents the effects of I1 1o su-
pernatants from allo-MLRs, nonactivated human PBMC,
plastic adherent monocytes, and basal medium alone on
keratinocyte growth at 48 hofculture. Percent stimulation
was compared with that obtained after culture in KGM.
Nonactivated monocyte and PBMC supernatants were ob-
tained from 48- and 72-h cultures, respectively. Allo-MLR
supernatants were obtained after7dofculture. Thenumbers
in parentheses equalthenumber of experiments performed.a-
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FIGURE 4. The effect of purified or
recombinant cytokines and growth factors
on keratinocyte growth. Keratinocytescul-
turedin I ml of fresh basal medium were
fed on day0only (openbars)or at 24-h in-
tervals (closedbars)with increasing concen-
trations ofGM-CSF (A), IL-3 (B), TGF-
0 (C), or IFN-y (D). Percent stimulation
was determined at 72 (D) or 96 (A, B, C)
h of culture and compared with that ob-
tained with basal medium alone(abscissa).
Our observations demonstrated that keratinocyte replication was inhibited at con-
centrations ofTGFR as low as 0.04-0.08 ng/ml basal medium (Fig. 4 C). The inhi-
bition wasfullyreversed when thecells were washed free ofcytokine and new growth
medium was added (datanot shown). Greaterthan 0.05 ng IFN-y/ml basal medium
was strongly inhibitory (Fig. 4 D), and washing the cultures free of IFN-y and the
addition of newgrowth medium demonstrated that theinhibitory effect was concen-
trationdependent and not completely reversible (data not shown). This agrees with
previously published reports (11, 17). Treatment of the cells with 1 ng/ml or more
IFN-y induced theexpression of class II molecules and suggests the terminal differen-
tiation of a subpopulation ofkeratinocytes. Severalother cytokines andgrowth factors,
including EGF, PDGF, FGF (basic), IL-1, IL-2, and M-CSF were not stimulatory
in this system (Table 1). However, PDGF and IL-1 were suppressive forkeratinocyte
growth at high concentrations.
Discussion
We have previously shown that the generation of a delayed-type immune response
in thehuman dermis leads to the growth and differentiation ofthe overlyingepidermis
(1). Detailed examination of this process is now possible through the development
of an in vitro assay for the growth of purified keratinocytes. In short-term assays,
we have tested themolecules secreted by T cells and monocytes and compared their
growth stimulating and inhibiting properties with those of pure, recombinant
cytokines.
Clear-cut growth stimulation occurred with purified T cells cultured with DC as
accessory cells. At 1% concentration of supernatant, this proved as effective as the1400
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TABLE I
The Effect of Various Cytokines and Growth Factors on
In Vitro Keratinocyte Proliferation
' Cytokines/growth factors were tested for their effects at 24, 48, 72, and 96
h of culture.
complete keratinocyte growth medium. Thenature of factors in Tcell medium might
include a variety of cytokines, some of which have recently been cloned. Addition
of IL-2, M-CSF, TGFR, or IFN-y either led to no effect on growth or in the case
of TGF0 and IFN-y, marked inhibition of growth at both high and low concentra-
tions. This was somewhat suprising in that the direct injection of human rIFN-y
into the skin leads to enhanced keratinocyte proliferation and thickening of the
epidermis (3, 4). We suspect, therefore, that IFN-y administrated in vivo promotes
the production of growth factors by other cells of the skin.
Two recombinant lymphokines proved to stimulatekeratinocyte growth (IL-3 and
GM-CSF). These novelfindings suggestthat IL-3 may regulate in vitrohuman ker-
atinocyte growth. The growth response to IL-3 is saturable at low concentrations
and suggests that keratinocytes possess a high affinity IL-3-R. The local production
ofIL-3 by activated, dermal T cells maythereforeregulate epidermal growth. GM-
CSF is also a molecule of some interest since it is synthesized by keratinocytes and
has the ability to capacitate freshly isolated murine Langerhans' cells fortheiracces-
sory function (18). It is therefore possible that in the presence ofT cell-derived lym-
phokines, keratinocytes may themselves secrete GM-CSF, and that this molecule
serves as an autocrine growth regulator.
T cells and their secretory repertoire may serve to regulate the epidermis in both
physiological and pathological situations. During ashort-term antigen-driven event,
keratinocyte growth, epidermal thickening, andclassII gene expression would serve
to enhance woundhealing, antigen presentation, and thebarrierfunction ofthe skin.
These T cell-derived molecules would help to amplify cell-mediated immunity by
recruiting keratinocytes as active participants. In contrast, the chronicity ofdiseases
such as psoriasis (19) and its associated T cell infiltrates could have adverse effects
on skin integrity.
Dissection of the comparative contributions of T cells and monocytes was made
possible by the use of purified DC as accessory cells (8). It wasclear that monocyte
culture supernatants contained inhibitory molecules, whereas T cell supernatants
gave growth stimulatory effects. Monocyte culture fluids may contain a number of
potentially inhibitory molecules. These include arachidonic acid metabolites such
as prostaglandin E2 and TNF (7, 20). Both are secreted in large amounts after the
Cytokine/growth factor Range tested" Mitogenic effect
IL-10 0.7-700 pg/ml None (inhibition at
700 pg/ml)
IL-2 0.002-6.8 ng/ml None
M-CSF 0.3-5 .0 ng/ml None
EGF 0.01-100 ng/ml None
FGF (basic) 0.01-45 ng/ml None
PDGF 0.6-2 .5 ng/ml None (inhibition at
2.5 ng/ml)uptake of particulates and exposure to LPS endotoxin (reviewed in reference 21).
Monocyte supernatants also have been shown to contain growth stimulants such
as IL-1, PDGF, fibroblast growth factor, and fibroblast TGFR (21). Their stimula-
tory activity on keratinocytes, if they exist, may be masked by the presence of the
previously described inhibitors.
Summary
We describe a bioassay that allows the in vitro investigation of the stimulatory
and suppressive factors derived from immune cells in short-term cultures of human
keratinocytes. In agreement with other assays, epidermal growth factor is not mito-
genic for human keratinocytes. Supernatant fluid from human PBMC stimulated
with Con A, from allo-MLRs, as well as supernatants from nonstimulated PBMC,
possess growth-promoting molecules. Our results'show that both activated and nonac-
tivated T cells release growth factors. Suppressive molecules are produced preferen-
tially by monocyte cultures. Two T cell products, IFN-y and transforming growth
factor R are both inhibitory for keratinocyte proliferation. Two other T cell prod-
ucts, IL-3 and GM-CSF, stimulate keratinocyte proliferation at nanogram concen-
trations. These results suggest the existence of regulatory circuits between the T
cells of a dermal inflammatory infiltrate and the overlying epidermal keratinocytes.
This may determine the fine control of epidermal proliferation and turnover leading
either to enhanced wound repair or skin pathology.
We are grateful to Dr. Erik Langhoff for help in the generation of MLR supernatants.
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